1-8 of 8
Authors: Eric Burton
Journal Article
Implications of sociodemographic and clinical factors on symptom burden: Age-specific survivorship care in the primary central nervous system tumor population Get access
Neuro-Oncology Practice, npae116, https://doi.org/10.1093/nop/npae116
Published: 26 November 2024
Journal Article
The COVID-19 pandemic experience for patients with central nervous system tumors: Differences in patient-reported outcomes and practice recommendations
Neuro-Oncology Practice, Volume 12, Issue 1, February 2025, Pages 76–86, https://doi.org/10.1093/nop/npae067
Published: 19 July 2024
Journal Article
Assessing sleep in primary brain tumor patients using smart wearables and patient-reported data: Feasibility and interim analysis of an observational study Get access
Neuro-Oncology Practice, Volume 11, Issue 5, October 2024, Pages 640–651, https://doi.org/10.1093/nop/npae048
Published: 24 May 2024
Journal Article
Exploring the prevalence and burden of sleep disturbance in primary brain tumor patients
Neuro-Oncology Practice, Volume 9, Issue 6, December 2022, Pages 526–535, https://doi.org/10.1093/nop/npac049
Published: 22 June 2022
Journal Article
The Montreal Cognitive Assessment (MoCA) in neuro-oncology: A pilot study of feasibility and utility in telehealth and in-person clinical assessments
Neuro-Oncology Practice, Volume 9, Issue 5, October 2022, Pages 429–440, https://doi.org/10.1093/nop/npac038
Published: 14 May 2022
Journal Article
Living with a central nervous system (CNS) tumor: findings on long-term survivorship from the NIH Natural History Study
Neuro-Oncology Practice, Volume 8, Issue 4, August 2021, Pages 460–474, https://doi.org/10.1093/nop/npab022
Published: 10 April 2021
Journal Article
Survival impact of prolonged postoperative radiation therapy for patients with glioblastoma treated with combined-modality therapy
Neuro-Oncology Practice, Volume 6, Issue 2, April 2019, Pages 112–123, https://doi.org/10.1093/nop/npy027
Published: 20 July 2018
Journal Article
Survival in elderly glioblastoma patients treated with bevacizumab-based regimens in the United States
Neuro-Oncology Practice, Volume 5, Issue 4, December 2018, Pages 251–261, https://doi.org/10.1093/nop/npy001
Published: 06 February 2018
